T 0462/21 of 05.05.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T046221.20220505
- Date of decision
- 5 May 2022
- Case number
- T 0462/21
- Online on
- 18 July 2022
- Petition for review of
- -
- Application number
- 10009914.2
- IPC class
- C07K 1/34
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Process for concentration of antibodies and therapeutic products thereof
- Applicant name
- Genentech, Inc.
Novartis AG - Opponent name
- -
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal Art 13(2)European Patent Convention Art 56European Patent Convention Art 123(2)
- Keywords
- Amendment of the case after summons
Amendments
Inventive step - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent with claims 1 to 20 of the main request filed as the second auxiliary request by letter dated 27 April 2022 and a description to be adapted.